We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
A19001 | Anti-Inflammatory Peptide 1 | 1079.3 | Inquiry | |
A19002 | Anti-Inflammatory Peptide 2 | 1084.3 | Inquiry | |
A19003 | Anti-Inflammatory Peptide 3 | 1065.3 | Inquiry | |
A19004 | Interleukin-6 Receptor Peptide | 1216.3 | Inquiry | |
A19006 | WP9QY, TNF-alpha Antagonist | 1226.4 | Inquiry | |
A19007 | C5a Receptor Agonist, mouse, human | 853.1 | Inquiry | |
A19008 | Linear C5a Receptor Antagonist, human, rat | 886.1 | Inquiry | |
A19009 | Cortistatin-29 (rat) | 3540.09 | C161H240N46O41S2 | Inquiry |
There are many members in the family of anti-inflammatory peptides, such as interleukein-4 (IL-4), IL-10, IL-13, IL-35, transforming growth factor-β (TGF-β) , TGF-p1. Anti-inflammatory peptides are a class of small intracellular peptides (5-140 kD) that are first synthesized into precursors, which are then cleaved by proteases to form active small peptides. These small peptides are non-structural proteins that are involved in inflammation and immune response.
IL-4 is a typical anti-inflammatory peptide that is released by activated T cells, mast cells and granulocytes. Mature IL-4 has 129 amino acid residues, contains three intramolecular disulfide bonds, and localizes to chromosome 5. The greatest feature of IL-4 is the ability to promote the conversion of T cells into anti-inflammatory Th2 cells. Signal transduction of IL-4 is mediated by the activated IL-4 receptor, which activates the JAK/STAT intracellular signaling pathway when IL-4 binds to its receptor. In addition, IL-4 can also reduce the synthesis of pro-inflammatory factors. Similar to IL-4, IL-10 also inhibits the release of pro-inflammatory factors and influences the balance of inflammatory and anti-inflammatory factors by reducing the activity of NF-κB.
Anti-Inflammatory peptides play an essential role in various infectious diseases, such as systemic inflammatory response syndrome, bronchial asthma, Hepatitis B virus (HBV) infection, and acute pancreatitis. It is reported that IL -4 is generally elevated in patients with acute infection, and there is still an increasing trend with the remission of the disease. Some studies have shown that IL-4 can block the production of cytokines by monocytes, inhibiting the release of inflammatory mediators such as TNF, IL-1, etc. IL-10 and TGF- β is also able to significantly inhibit the synthesis and release of pro-inflammatory cytokines by immune cells. In conclusion, Anti-Inflammatory peptides exert anti-inflammatory and protective effects on the body in most infectious diseases, providing an attractive way for the cure of diseases.
References
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com